ClinicalTrials.gg
CompletedNCT01588197Updated Jun 14, 2019Results posted

Real-Time fMRI Feedback Effects on Pain Perception

An interventional study of Attention/Distraction Strategy and Stimulus Quality/Severity Strategy in Cognitive Pain Control, sponsored by Medical University of South Carolina. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-06-14.

Sponsored by Medical University of South Carolina · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Nov 2010, registered Feb 2012).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The purpose of this study is to determine whether real-time functional magnetic resonance imaging may be a viable treatment for chronic pain in the future.

Read the detailed description

Twenty-four healthy volunteers will undergo a series of four fMRI scanning sessions wherein thermal pain stimuli will be used to elicit activation of the pain neuro-matrix. All participants will undergo thermal pain threshold testing before and after fMRI scan. Participants will also rate the painfulness and unpleasantness of the thermal stimuli applied before fMRI and after fMRI. All participants will be given prompts to apply a set of cognitive pain-control strategies. Half of the participants will receive real-time fMRI feedback of activity in the Right Anterior Cingulate Cortex (rACC) and the other half will receive real-time fMRI feedback of activity in the Prefrontal Cortex (PFC). It is hypothesized that those receiving real-time feedback of brain activity thought to be involved with analgesic effects will demonstrate greater analgesia associated with the application of the cognitive control techniques after fMRI paradigm (decreased pain intensity and unpleasantness ratings and increased thermal pain thresholds) than those who are not given feedback before fMRI paradigm.

02

Conditions studied

  • Cognitive Pain Control

Browse trials for

Keywords

  • Pain
  • fMRI
  • real time
03

In context

Pain

2,450 studies on the registry are indexed under Pain; 945 are open to participants now.

This study's enrollment of 20 is below the median of 70 across 2,101 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Medical University of South Carolina is the lead sponsor of 871 studies on the registry; 163 are open to participants now.

Of its 131 completed or terminated interventional studies of FDA-regulated products, 104 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy adults ages 18-65

Exclusion criteria

Exclusion Criteria:

  • Clinical depression
  • Anxiety
  • Substance dependence or chronic pain
  • Ferrous metal implants
  • Cardiac pacemakers or other implanted medical devices that might be adversely impacted by the MRI scanner magnetic field
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    ACC Real Time fMRI Feedback

    Each participant will undergo thermal pain threshold assessments ten times using the Medoc Pathway System with MRI-compatible ATS Thermode (30mmX30mm; Medoc Inc, Israel). Participants will be instructed to "focus on the thermal stimuli" for the first 5 trials, and to engage in three cognitive pain inhibition strategies (Attention/Distraction Strategy, Stimulus Quality/Severity Strategy, and the Control Strategy. The participants will be randomly assigned to receive Real Time fMRI Feedback of inverse activation in the rACC after each pain/rest block during the last 3 fMRI scans in the form of two simple thermometer images on the in-scanner computer display.

    Behavioral: Attention/Distraction Strategy · Behavioral: Stimulus Quality/Severity Strategy · Behavioral: Control Strategy

  • Experimental
    PFC Real Time fMRI Feedback

    Each participant will undergo thermal pain threshold assessments ten times using the Medoc Pathway System with MRI-compatible ATS Thermode (30mmX30mm; Medoc Inc, Israel). Participants will be instructed to "focus on the thermal stimuli" for the first 5 trials, and to engage in three cognitive pain inhibition strategies (Attention/Distraction Strategy, Stimulus Quality/Severity Strategy, and the Control Strategy. The participants will be randomly assigned to receive Real Time fMRI Feedback of inverse activation in the PFC after each pain/rest block during the last 3 fMRI scans in the form of two simple thermometer images on the in-scanner computer display.

    Behavioral: Attention/Distraction Strategy · Behavioral: Stimulus Quality/Severity Strategy · Behavioral: Control Strategy

Interventions

  • BehavioralAttention/Distraction Strategy

    One of three Cognitive Pain Inhibition Strategies. The Participant will be instructed to attend away from the thermal stimulus (for example, to the other side of the body). Vividly imagine they are somewhere else, or engage in a high-demanding mental task such as counting backward by 7's or completing math problems to distract from the experience

  • BehavioralStimulus Quality/Severity Strategy

    One of three Cognitive Pain Inhibition Strategies. The Participant will be instructed to attempt to perceive the stimulus as a neutral sensory experience rather than pain. Attempt to perceive the stimulus as low intensity rather than high intensity.

  • BehavioralControl Strategy

    One of three Cognitive Pain Inhibition Strategies. The Participant will be instructed to attempt to take control of their perception of the painful experience.

06

What researchers measure

Primary outcomes

  1. Average Unpleasantness

    All participants will undergo thermal pain threshold testing directly before (Baseline) and after MRI. Participants will be asked to rate pain unpleasantness, on a scale of 0-10, before the fMRI Paradigm (Baseline) and directly after the fMRI paradigm (after MRI). 0="no unpleasantness" and 10="worst unpleasantness imaginable"

    Time frame: Before and After fMRI Paradigm, an average of 2 hours

  2. Average Pain Rating

    All participants will undergo thermal pain threshold testing directly before (Baseline) and after MRI scan.Participants will be asked to rate painfulness of the thermal stimuli applied, on a scale of 0-10, before the fMRI Paradigm (Baseline) and directly after the fMRI paradigm (after MRI). 0="no pain" and 10="worst pain imaginable"

    Time frame: Before and After fMRI Paradigm, an average of 2 hours

  3. Ability to Distract

    All participants will undergo thermal pain threshold testing before and after fMRI paradigm. Participants will rate the ability to distract themselves from the thermal stimuli, on a scale of 0-10, before fMRI paradigm (Baseline) and after fMRI paradigm, 0="not able to distract at all" and 10="completely able to distract". A Higher rating represents greater ability to distract from thermal pain stimuli.

    Time frame: Before and After fMRI Paradigm, an average of 2 hours

07

Results

Posted Jun 14, 2019

Participant flow

Participant flow — Overall Study
MilestoneACC Real Time fMRI FeedbackPFC Real Time fMRI Feedback
Started1010
Completed99
Not completed11
Withdrew: Lack of efficacy01
Withdrew: No mri10

Outcome measures

PrimaryAverage Unpleasantness

All participants will undergo thermal pain threshold testing directly before (Baseline) and after MRI. Participants will be asked to rate pain unpleasantness, on a scale of 0-10, before the fMRI Paradigm (Baseline) and directly after the fMRI paradigm (after MRI). 0="no unpleasantness" and 10="worst unpleasantness imaginable"

Time frame:
Before and After fMRI Paradigm, an average of 2 hours
Reported as:
Mean · units on a scale
Average Unpleasantness
units on a scaleACC Real Time fMRI FeedbackPFC Real Time fMRI Feedback
Before fMRI Paradigm3.75 ± 2.483.56 ± 2.22
After fMRI Paradigm3.30 ± 2.394.28 ± 2.82
PrimaryAverage Pain Rating

All participants will undergo thermal pain threshold testing directly before (Baseline) and after MRI scan.Participants will be asked to rate painfulness of the thermal stimuli applied, on a scale of 0-10, before the fMRI Paradigm (Baseline) and directly after the fMRI paradigm (after MRI). 0="no pain" and 10="worst pain imaginable"

Time frame:
Before and After fMRI Paradigm, an average of 2 hours
Reported as:
Mean · units on a scale
Average Pain Rating
units on a scaleACC Real Time fMRI FeedbackPFC Real Time fMRI Feedback
Before fMRI Paradigm3.79 ± 2.203.64 ± 2.30
After fMRI Paradigm3.88 ± 2.214.43 ± 2.23
PrimaryAbility to Distract

All participants will undergo thermal pain threshold testing before and after fMRI paradigm. Participants will rate the ability to distract themselves from the thermal stimuli, on a scale of 0-10, before fMRI paradigm (Baseline) and after fMRI paradigm, 0="not able to distract at all" and 10="completely able to distract". A Higher rating represents greater ability to distract from thermal pain stimuli.

Time frame:
Before and After fMRI Paradigm, an average of 2 hours
Reported as:
Mean · units on a scale
Ability to Distract
units on a scaleACC Real Time fMRI FeedbackPFC Real Time fMRI Feedback
Before fMRI Paradigm4.92 ± 1.963.83 ± 1.25
After fMRI Paradigm4.41 ± 2.154.02 ± 1.72

Adverse events

Collected over 1 year. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Real Time fMRI Feedback0/9 (0%)0/9 (0%)0/9 (0%)
No Feedback0/9 (0%)0/9 (0%)0/9 (0%)

Baseline characteristics

2 participants did not complete MRI scanning and so were not included in analyses

Age, Categorical
Age, Categorical(Participants)ACC Real Time fMRI FeedbackPFC Real Time fMRI FeedbackTotal
<=18 years000
Between 18 and 65 years9918
>=65 years000
Age, Continuous
Age, Continuous(years)ACC Real Time fMRI FeedbackPFC Real Time fMRI FeedbackTotal
Mean28 ± 7.6524.78 ± 3.9026.39 ± 5.95
Sex: Female, Male
Sex: Female, Male(Participants)ACC Real Time fMRI FeedbackPFC Real Time fMRI FeedbackTotal
Female549
Male459
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)ACC Real Time fMRI FeedbackPFC Real Time fMRI FeedbackTotal
White Non-Hispanic8917
Black or African American101
Region of Enrollment
Region of Enrollment(Participants)ACC Real Time fMRI FeedbackPFC Real Time fMRI FeedbackTotal
United States9918
08

Study locations

1 site
  • Medical University of South Carolina
    Charleston, South Carolina 29425, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 14, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01588197
Responsible party
Sponsor
First posted
Apr 30, 2012
Start date
Nov 2010
Primary completion
Dec 2016
Completion
Dec 2016
Results posted
Jun 14, 2019
Last update
Jun 14, 2019

Study contacts

Jeffery J Borckardt, PhD
principal investigator · Medical University of South Carolina
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion